YHR050W-A Antibody

What is YHR050W-A and why is it studied in yeast research?

YHR050W-A is a protein encoded by the YHR050W-A gene in Saccharomyces cerevisiae (Baker's yeast), specifically in the strain ATCC 204508/S288c. This protein has been assigned the UniProt accession number Q05451 . Studying YHR050W-A contributes to our understanding of yeast cellular processes and can provide insights into conserved mechanisms across eukaryotes. The YHR050W-A antibody (product code CSB-PA567851XA01SVG) is a valuable research tool for detecting and studying this protein in various experimental contexts .

The importance of this antibody in research stems from the model organism status of S. cerevisiae, which serves as an excellent system for studying fundamental cellular processes that are often conserved in more complex eukaryotes. Research involving YHR050W-A requires carefully validated antibodies, as approximately 20-30% of published research may utilize antibodies that fail to recognize their intended targets .

What validation methods should I use to confirm YHR050W-A antibody specificity?

Validating antibody specificity is critical for ensuring reliable experimental results. Two primary validation approaches are recommended:

Genetic validation approach: This is the most reliable method, involving:

• Testing the antibody in both parental yeast strains and YHR050W-A knockout strains

• Comparing signal intensity between wild-type and knockout samples

• Ensuring complete signal loss in knockout samples for specific antibodies

Orthogonal validation approach: While somewhat suitable for Western blot, this approach has limitations for immunofluorescence applications:

• Comparing antibody detection with known characteristics of YHR050W-A

• Using multiple antibodies targeting different epitopes of the same protein

• Correlating results with other detection methods (e.g., mass spectrometry)

Research indicates that genetic validation strategies generate far more robust characterization data, especially for immunofluorescence applications, where only 38% of antibodies validated by orthogonal methods were confirmed using knockout controls, compared to 80% of genetically validated antibodies .

How should I handle and store YHR050W-A antibody for optimal performance?

Proper handling and storage of YHR050W-A antibody is essential for maintaining its performance and extending its usable life. Based on standard practices for research antibodies:

• Storage temperature: Store antibody aliquots at -20°C for long-term storage

• Aliquoting: Divide the stock solution (typically 2ml/0.1ml as supplied) into small single-use aliquots to avoid repeated freeze-thaw cycles

• Working dilutions: Prepare working dilutions on the day of the experiment

• Transport conditions: Keep on ice during experimental procedures

• Contamination prevention: Use sterile techniques when handling the antibody

Implementing these practices will help maintain antibody sensitivity and specificity, which is particularly important given that antibody quality can significantly impact experimental reproducibility in yeast protein research.

What are the optimal conditions for using YHR050W-A antibody in Western blot applications?

For optimal Western blot results with YHR050W-A antibody, implement the following methodological approach:

• Sample preparation:

  • Extract proteins using standard yeast lysis buffers containing protease inhibitors

  • For intracellular proteins like YHR050W-A, use cell lysates rather than media fractions

  • Denature samples in loading buffer containing SDS and β-mercaptoethanol

• Gel electrophoresis and transfer:

  • Use 10-12% SDS-PAGE gels for optimal resolution

  • Transfer to PVDF or nitrocellulose membranes at 100V for 60-90 minutes

• Blocking and antibody incubation:

  • Block membranes with 5% non-fat dry milk or BSA

  • Use YHR050W-A antibody at 1:1000 dilution (optimize as needed)

  • Incubate overnight at 4°C with gentle rocking

• Critical controls:

  • Include YHR050W-A knockout yeast lysate as a negative control

  • Use wild-type yeast lysate as a positive control

  • Consider loading gradient to assess antibody sensitivity and signal linearity

Research shows that 80-89% of antibodies recommended based on genetic validation strategies can successfully detect their target proteins in Western blot applications . Proper validation using knockout controls is essential as approximately 31% of Western blot publications may use antibodies that do not specifically detect their intended targets .

How should I optimize YHR050W-A antibody for immunoprecipitation studies?

For successful immunoprecipitation (IP) of YHR050W-A, follow this systematic optimization protocol:

• Lysis conditions:

  • Use non-denaturing lysis buffers to preserve protein structure and interactions

  • For intracellular yeast proteins like YHR050W-A, optimize using different detergent concentrations (e.g., 0.1-1% NP-40 or Triton X-100)

• Antibody binding:

  • Pre-clear lysate with Protein A/G beads to reduce non-specific binding

  • Incubate 1-5 μg of YHR050W-A antibody with 500-1000 μg of protein lysate

  • Allow 2-4 hours or overnight incubation at 4°C with rotation

• Bead selection and washing:

  • Choose appropriate beads (Protein A for rabbit antibodies, Protein G for mouse)

  • Perform stringent washes (typically 4-5) with decreasing detergent concentrations

  • Include a final wash with detergent-free buffer

• Elution and verification:

  • Elute proteins with SDS loading buffer at 95°C for 5 minutes

  • Verify IP success using Western blot with a validated YHR050W-A antibody

Research indicates that approximately 35% of published IP studies may use antibodies that fail to immunocapture their target proteins . Therefore, rigorous validation of IP efficiency is crucial for reliable results.

What protocols work best for immunofluorescence with YHR050W-A antibody?

For robust immunofluorescence (IF) detection of YHR050W-A in yeast cells, implement this methodological approach:

• Cell preparation:

  • Culture yeast cells to mid-log phase

  • Fix with 4% paraformaldehyde for 15-30 minutes

  • Digest cell wall with zymolyase in sorbitol buffer

  • Permeabilize with 0.1% Triton X-100

• Antibody incubation and imaging:

  • Block with 3-5% BSA for 30-60 minutes

  • Incubate with YHR050W-A antibody (1:100-1:500 dilution) for 2 hours at room temperature or overnight at 4°C

  • Apply fluorophore-conjugated secondary antibody for 1 hour at room temperature

  • Counterstain nuclei with DAPI

• Validation strategy:

  • Use the mosaic approach that images parental and knockout cells in the same visual field to reduce imaging and analysis biases

  • Include both positive and negative controls in each experiment

According to research findings, immunofluorescence applications have the highest failure rate among antibody applications, with approximately 22% of published studies using antibodies unable to immunolocalize their target proteins . Among these publications, 88% contained no validation data , highlighting the importance of proper controls and validation.

How can I use YHR050W-A antibody to study protein-protein interactions?

For investigating protein-protein interactions involving YHR050W-A, consider these advanced methodological approaches:

• Co-immunoprecipitation (Co-IP):

  • Use non-denaturing lysis buffers to preserve protein complexes

  • Perform IP with YHR050W-A antibody following the protocol in section 2.2

  • Analyze co-precipitated proteins by mass spectrometry or Western blot with antibodies against suspected interaction partners

  • Include appropriate controls: IgG control, YHR050W-A knockout lysate

• Proximity Ligation Assay (PLA):

  • Fix and permeabilize yeast cells as for standard IF

  • Incubate with YHR050W-A antibody and antibody against potential interaction partner

  • Apply PLA probes and perform ligation and amplification steps

  • Analyze signal dots representing proteins in close proximity (30-40 nm)

• Cross-linking Mass Spectrometry (XL-MS):

  • Cross-link proteins in vivo or in cell lysates

  • Immunoprecipitate with YHR050W-A antibody

  • Digest and analyze by mass spectrometry to identify cross-linked peptides

These methods require thoroughly validated antibodies to avoid false positives or negatives. Validation through genetic approaches is strongly recommended for these advanced applications, as research shows that antibodies validated through genetic strategies demonstrate 80% concordance with knockout validation, compared to only 38% for orthogonal validation strategies in complex applications .

What approaches are recommended for studying post-translational modifications of YHR050W-A?

Investigating post-translational modifications (PTMs) of YHR050W-A requires specialized methodologies:

• Phosphorylation analysis:

  • Treat cells with phosphatase inhibitors during lysis

  • Enrich phosphorylated proteins using phospho-affinity chromatography

  • Perform IP with YHR050W-A antibody

  • Analyze by Western blot using phospho-specific antibodies or by mass spectrometry

  • Compare PTM patterns under different cellular conditions

• Ubiquitination/SUMOylation detection:

  • Express tagged ubiquitin/SUMO in yeast cells

  • Perform denaturing IP to disrupt non-covalent interactions

  • Detect modified YHR050W-A using antibodies against the tag or YHR050W-A itself

  • Confirm specificity using YHR050W-A knockout controls

• Mass spectrometry-based PTM mapping:

  • Immunoprecipitate YHR050W-A under conditions that preserve PTMs

  • Perform protease digestion (trypsin, chymotrypsin, or multiple proteases)

  • Analyze peptides by LC-MS/MS with PTM discovery settings

  • Validate findings with appropriate controls and orthogonal methods

Each of these approaches requires careful experimental design and controls to ensure specificity. The choice of antibody is critical, as antibody performance can vary considerably between applications .

How can I quantitatively analyze YHR050W-A expression levels across different experimental conditions?

For precise quantitative analysis of YHR050W-A expression, employ these methodological strategies:

• Quantitative Western blot:

  • Include a standard curve with recombinant YHR050W-A protein

  • Use fluorescent secondary antibodies for linear signal detection

  • Process multiple biological replicates (n≥3)

  • Normalize to multiple housekeeping proteins

  • Analyze using densitometry software with background subtraction

• Immunofluorescence quantification:

  • Use the mosaic imaging approach to compare parental and knockout cells in the same field

  • Maintain identical acquisition settings across all samples

  • Analyze signal intensity with automated image analysis software

  • Calculate signal-to-background ratio to determine specificity

  • Process multiple cells (n>50) across multiple fields

• Flow cytometry:

  • Prepare yeast spheroplasts with zymolyase treatment

  • Permeabilize and stain with YHR050W-A antibody

  • Include appropriate controls (secondary-only, isotype control)

  • Gate on appropriate cell populations

  • Analyze signal distribution and median fluorescence intensity

When comparing expression levels across multiple conditions, statistical analysis is essential. Use appropriate statistical tests and report p-values and confidence intervals. Remember that approximately 20-30% of the scientific literature may contain figures generated with antibodies that do not specifically recognize their intended targets , highlighting the importance of thorough validation before quantitative analysis.

What are common issues when using YHR050W-A antibody and how can I resolve them?

When working with YHR050W-A antibody, researchers commonly encounter several issues that can be systematically addressed:

Research indicates that even antibodies from the same supplier can show variable performance, and approximately 31% of Western blot publications may use antibodies that fail to specifically detect their targets . Therefore, thorough validation and optimization are essential troubleshooting steps.

How can I systematically validate YHR050W-A antibody to ensure reproducible results?

Implement this comprehensive validation workflow to ensure reproducible results with YHR050W-A antibody:

• Initial specificity assessment:

  • Compare signal between wild-type and YHR050W-A knockout yeast

  • Look for complete signal loss in knockout samples for truly specific antibodies

  • Test multiple antibody concentrations to optimize signal-to-noise ratio

• Cross-validation across methods:

  • Verify antibody performance in multiple applications (WB, IP, IF)

  • Test under different sample preparation conditions

  • Compare results with alternative antibodies against the same target

• Documentation and experimental controls:

  • Document specific antibody details (vendor, catalog number, lot, RRID)

  • Include knockout controls in all experiments

  • For Western blot, include molecular weight markers

  • For IF, use the mosaic approach with parental and knockout cells

• Reproducibility verification:

  • Test across multiple biological replicates

  • Verify consistent results across different antibody lots

  • Consider independent validation by different researchers

This validation process is essential as research has shown that 20-30% of figures in the scientific literature may be generated using antibodies that do not recognize their intended targets . Proper validation substantially increases experimental reproducibility.

How should I interpret contradictory results when using YHR050W-A antibody in different applications?

When faced with contradictory results across different applications using YHR050W-A antibody:

• Assess application-specific performance:

  • Antibody performance often varies between applications (WB, IP, IF)

  • Research shows that an antibody's success in one application does not necessarily predict performance in another

  • Specifically validate for each intended application

• Consider epitope accessibility factors:

  • Protein folding affects epitope exposure differently in various applications

  • Denaturing conditions (WB) vs. native conditions (IP) can dramatically alter recognition

  • Fixation methods for IF can mask or expose different epitopes

• Systematic reconciliation approach:

  • Return to genetic validation using knockout controls for each application

  • If contradictions persist, consider using alternative antibodies

  • Determine if protein complexes or post-translational modifications might explain differential recognition

  • When possible, verify with non-antibody-based methods (e.g., mass spectrometry)

Studies have shown that antibody performance correlation between applications is often poor, requiring application-specific validation . When publishing contradictory results, clearly document validation methods for each application to ensure scientific rigor.

How can I use YHR050W-A antibody in multi-omics research approaches?

Integrating YHR050W-A antibody into multi-omics research requires sophisticated methodological approaches:

• Antibody-based proteomics integration:

  • Use YHR050W-A antibody for immunoprecipitation followed by mass spectrometry

  • Compare protein interactome data with transcriptomics profiles

  • Correlate YHR050W-A protein levels (detected by WB) with RNA-seq expression data

  • Integrate with genomics data to assess genotype-phenotype relationships

• Spatial proteomics applications:

  • Apply IF with YHR050W-A antibody combined with subcellular markers

  • Implement high-content imaging for quantitative spatial analysis

  • Correlate localization patterns with functional genomics data

  • Validate localization using the mosaic approach with knockout controls

• Functional validation strategies:

  • Connect antibody-based detection with CRISPR-based functional screens

  • Correlate protein abundance (antibody-based) with metabolomic profiles

  • Integrate with structural biology data for mechanistic insights

This integration requires comprehensive antibody validation, as approximately 88% of immunofluorescence publications lack validation data . Proper documentation of antibody details using Research Resource Identification (RRID) numbers facilitates data integration across studies .

What are the latest technological advances in antibody validation relevant to YHR050W-A research?

Recent technological advances have significantly improved antibody validation methodologies:

• Standardized knockout validation platforms:

  • Scaled characterization approaches using parental and knockout cell lines

  • Side-by-side comparisons of antibodies against the same target

  • Systematic validation across multiple applications (WB, IP, IF)

• Advanced imaging validation techniques:

  • Mosaic imaging of parental and knockout cells in the same visual field

  • Reduction of imaging and analysis biases through direct visual comparison

  • Automated image analysis for quantitative validation metrics

• Community resources and standards:

  • Centralized repositories of antibody validation data (e.g., ZENODO)

  • Assignment of Research Resource Identification (RRID) to each antibody

  • Integration with the Antibody Registry and RRID Portal for data dissemination

  • Technical peer review of antibody characterization reports by scientific advisors

These advances address the significant problem of antibody reliability, where studies have found that 20-30% of published figures may be generated using antibodies that do not recognize their intended targets . Implementing these validation approaches for YHR050W-A antibody research ensures higher reproducibility and scientific rigor.

How can I design experiments to study YHR050W-A function under various stress conditions?

For studying YHR050W-A function under stress conditions, implement this comprehensive experimental design:

• Systematic stress condition selection:

  • Choose physiologically relevant stressors (oxidative, temperature, nutrient deprivation)

  • Apply stress in both acute and chronic models

  • Include genetic perturbations that mimic stress responses

  • Design proper controls for each stress condition

• Experimental variables and controls:

  • Define independent variables (stress type, duration, intensity)

  • Identify dependent variables (YHR050W-A expression, localization, modifications)

  • Control extraneous variables (growth phase, media composition)

  • Include both wild-type and YHR050W-A knockout strains as controls

• Sample size and statistical considerations:

  • Determine appropriate sample size through power analysis

  • Plan for multiple biological and technical replicates

  • Select appropriate statistical tests based on data distribution

  • Control for multiple testing when examining numerous conditions

• Integrated readout methods:

  • Quantify YHR050W-A protein levels by validated Western blot

  • Assess localization changes via immunofluorescence

  • Examine protein-protein interactions through co-IP under stress

  • Monitor PTM changes using specialized antibodies or mass spectrometry

This experimental design framework follows established principles of sound experimental methodology while incorporating antibody validation strategies to ensure reliable detection of YHR050W-A across different stress conditions .